Separate terms with OR to return results that match either term.
 
Clear All

10,000 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date (Ascending) Status
24987-0111-14 24987-0111 Nilutamide Nilandron 150.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral July 15, 2013 Aug. 31, 2017 No Longer Used
63323-0172-45 63323-0172 Carboplatin Carboplatin 10.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Sept. 15, 2009 Aug. 31, 2017 In Use
50090-1600-03 50090-1600 ondansetron hydrochloride Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Jan. 5, 2015 Aug. 31, 2017 In Use
76126-0075-01 76126-0075 Mesna Mesna 100.0 mg/mL Ancillary Therapy Chemoprotective Detoxifying Agent Intravenous July 19, 2014 Sept. 1, 2017 No Longer Used
00074-6479-32 00074-6479 Cyclosporine Modified Gengraf 100.0 mg/1 Ancillary Therapy Immunomodulator Calcineurin Inhibitor Oral May 24, 2010 Sept. 16, 2017 No Longer Used
42195-0105-06 42195-0105 Dexamethasone Decadron DP 1.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Sept. 11, 2017 Sept. 25, 2017 No Longer Used
42195-0105-12 42195-0105 Dexamethasone Decadron DP 1.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Sept. 11, 2017 Sept. 25, 2017 No Longer Used
66992-0015-01 66992-0015 Dexamethasone Decadron 1.5 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Sept. 11, 2017 Sept. 25, 2017 No Longer Used
00173-0569-00 00173-0569 Ondansetron Hydrochloride Zofran ODT 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral March 1, 1999 Sept. 30, 2017 No Longer Used
25021-0202-15 25021-0202 Carboplatin Carboplatin 10.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Oct. 31, 2013 Sept. 30, 2017 No Longer Used
00093-0784-05 00093-0784 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 9, 2008 Sept. 30, 2017 No Longer Used
51991-0749-33 51991-0749 Dutasteride Dutasteride 0.5 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Nov. 20, 2015 Sept. 30, 2017 No Longer Used
00088-1206-32 00088-1206 Dolasetron mesylate Anzemet 100.0 mg/5mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Sept. 11, 1997 Sept. 30, 2017 No Longer Used
76237-0227-30 76237-0227 Prednisone Prednisone 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Oct. 12, 2011 Sept. 30, 2017 No Longer Used
76237-0228-30 76237-0228 Prednisone Prednisone 10.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Dec. 20, 2011 Sept. 30, 2017 No Longer Used
43063-0201-01 43063-0201 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Dec. 10, 2009 Oct. 2, 2017 No Longer Used
43063-0201-30 43063-0201 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Dec. 10, 2009 Oct. 2, 2017 No Longer Used
43063-0201-90 43063-0201 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Dec. 10, 2009 Oct. 2, 2017 No Longer Used
60429-0272-05 60429-0272 Flutamide Flutamide 125.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral Sept. 18, 2001 Oct. 10, 2017 No Longer Used
00409-4755-11 00409-4755 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Oct. 24, 2014 Oct. 16, 2017 In Use
00409-4755-12 00409-4755 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous Oct. 24, 2014 Oct. 16, 2017 In Use
67979-0001-02 67979-0001 Valrubicin Valstar 40.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravesical Oct. 1, 1998 Oct. 17, 2017 In Use
00015-1911-13 00015-1911 Ixabepilone Ixempra Chemotherapy Antitumor Antibiotic Epothilones Intravenous Oct. 16, 2007 Oct. 31, 2017 No Longer Used
61703-0341-06 61703-0341 Vinorelbine Vinorelbine 10.0 mg/mL Chemotherapy Antimitotic Agent Vinca Alkaloid Intravenous April 9, 2007 Oct. 31, 2017 No Longer Used
00009-1111-01 00009-1111 Irinotecan Hydrochloride Camptosar 20.0 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous June 14, 1996 Oct. 31, 2017 In Use

Found 10,000 results in 5 millisecondsExport these results